Atlas Trials

Study in Subjects With Mild-to-Moderate Alzheimer's Dementia

Clinical trial NCT05834296 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05834296
Sponsor
Alzamend Neuro, Inc.
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Alzheimer Disease
Start date
2023-07-05
Primary completion
2028-03-03
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.